Evolus Inc (EOLS)

May 23, 2026

Precision Trading with Evolus Inc. (EOLS) Risk Zones - Stock Traders Daily

May 23, 2026

May 22, 2026

Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It - Benzinga

May 22, 2026

May 20, 2026

Evolus Q1 2026 earnings preview - MSN

May 20, 2026

May 19, 2026

Evolus to Participate in The Jefferies Global Healthcare Conference - Business Wire

May 19, 2026

May 16, 2026

Earnings call transcript: Evolus Inc Q1 2026 misses EPS forecast, stock rises - Investing.com Nigeria

May 16, 2026

May 14, 2026

Evolus Completes Key NUCEIVA Safety Study, Easing Risk for Aesthetic Toxin Investors - TipRanks

May 14, 2026

May 12, 2026

Evolus To Roll Out Estyme Injectable Hyaluronic Acid Fillers in Europe - The Dermatology Digest

May 12, 2026

May 11, 2026

Evolus (EOLS) to Launch Estyme Injectable Collection in Europe - GuruFocus

May 11, 2026

May 11, 2026

Evolus to launch Estyme dermal filler line in Europe on May 16 - Investing.com UK

May 11, 2026

May 11, 2026

Evolus to Launch Estyme Dermal Fillers in Europe - Orange County Business Journal

May 11, 2026

May 11, 2026

Evolus to launch Estyme dermal filler line in Europe on May 16 By Investing.com - Investing.com South Africa

May 11, 2026

May 11, 2026

Evolus, Inc. Launches Estyme Injectable Hyaluronic Acid Gels Collection in Europe - marketscreener.com

May 11, 2026

May 11, 2026

Evolus launches Estyme in Europe with commercial debut targeted for May 16 - Traders Union

May 11, 2026

May 11, 2026

Evolus Announces Commercial Launch Of Estyme® Injectable Hyaluronic Acid Gels In Europe - TradingView

May 11, 2026

May 11, 2026

Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe - ChartMill

May 11, 2026

May 11, 2026

What is HC Wainwright's Estimate for Evolus Q2 Earnings? - MarketBeat

May 11, 2026

May 11, 2026

Evolus Plans to Launch Estyme Collection in Europe - Moomoo

May 11, 2026

May 11, 2026

Evolus May 2026 slides: HA innovation, Jeuveau data support dual strategy - Investing.com Australia

May 11, 2026

May 10, 2026

Evolus May 2026 slides: HA innovation, Jeuveau data support dual strategy By Investing.com - Investing.com South Africa

May 10, 2026

May 08, 2026

Evolus | 4: Statement of changes in beneficial ownership of securities-Officer MOATAZEDI DAVID - Moomoo

May 08, 2026

May 07, 2026

Evolus, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:EOLS) 2026-05-07 - Seeking Alpha

May 07, 2026

May 07, 2026

Evolus reiterates 2026 net revenue of $327M-$337M while targeting a low to mid-single-digit adjusted EBITDA margin - MSN

May 07, 2026

May 06, 2026

Evolus (EOLS) Q2 2025 Earnings Call Transcript - AOL.com

May 06, 2026

May 06, 2026

Evolus Earnings Call Highlights Profitable Growth Path - TipRanks

May 06, 2026

May 06, 2026

Analysts Are Bullish on Top Healthcare Stocks: CG Oncology, Inc. (CGON), Evolus (EOLS) - The Globe and Mail

May 06, 2026

May 06, 2026

Evolus Faces Heightened Operational Risk from Overseas Manufacturing and Disaster Recovery Gaps - TipRanks

May 06, 2026

May 05, 2026

PREVIEW-Weight-loss revolution sparks new appetite for aesthetics firms - Sahm

May 05, 2026

May 05, 2026

Stifel Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $17 - Moomoo

May 05, 2026

May 05, 2026

A Quick Look at Today's Ratings for Evolus(EOLS.US), With a Forecast Between $13 to $17 - Moomoo

May 05, 2026

May 05, 2026

Evolus, Inc. (NASDAQ:EOLS) Q1 2026 Earnings Call Transcript - Insider Monkey

May 05, 2026

May 05, 2026

Evolus, Inc. 2026 Q1 Financial Report: Key Risks, Financials, and Business Updates - Minichart

May 05, 2026

May 05, 2026

Earnings call transcript: Evolus misses Q1 2026 EPS forecast, revenue up - Investing.com UK

May 05, 2026

May 05, 2026

Evolus, Inc. (EOLS) reports Q1 loss, tops revenue estimates - MSN

May 05, 2026

May 05, 2026

Evolus Sees 2026 Rev $327M-$337M >EOLS - Moomoo

May 05, 2026

May 04, 2026

Is Evolus (EOLS) Finally Turning the Corner on Profitability? - Kavout

May 04, 2026

May 04, 2026

Evolus Q1 2026 Earnings Call Transcript - MarketBeat

May 04, 2026

May 04, 2026

Evolus | 8-K: Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year Outlook - Moomoo

May 04, 2026

May 04, 2026

Evolus, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 04, 2026

May 04, 2026

Evolus | 10-Q: Q1 2026 Earnings Report - Moomoo

May 04, 2026

May 04, 2026

Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 04, 2026

May 04, 2026

Evolus Inc (NASDAQ:EOLS) Q1 2026 Earnings: Narrowed Loss and Positive EBITDA Drive After-Hours Rally - ChartMill

May 04, 2026

May 04, 2026

Evolus Q1 Earnings Call Highlights - Yahoo Finance

May 04, 2026

May 04, 2026

Evolus Shares up After Q1 Revenue Tops Consensus - Orange County Business Journal

May 04, 2026

May 04, 2026

Earnings call transcript: Evolus misses Q1 2026 EPS forecast, revenue up By Investing.com - Investing.com South Africa

May 04, 2026

May 04, 2026

Evolus (EOLS) Q1 2026 Earnings Transcript - AOL.com

May 04, 2026

May 04, 2026

EOLS Reports Strong Q1 Revenue and Positive Adjusted EBITDA - GuruFocus

May 04, 2026

May 04, 2026

Evolus, Inc. 1Q 2026: Revenue $73.14M, EPS ($0.16) — 10-Q Summary - TradingView

May 04, 2026

May 04, 2026

Evolus (NASDAQ: EOLS) grows Q1 2026 sales but remains unprofitable - Stock Titan

May 04, 2026